NESP is contraindicated in patients with: Uncontrolled hypertension.
Known sensitivity to products derived from mammalian cells.
Known hypersensitivity to darbepoetin alfa or any of the excipients found in NESP.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.